On Monday 12 January 2009 02:42:43 Ian Tickle wrote:

> Also I did a 'Google vote' for the two terms.  'Structure amplitude' has
> 11300 hits.  'Structure factor amplitude' has only 4750.  So all round I
> would say that 'structure amplitude' wins by a considerable margin.

The field of crystagooglography is relatively young,
and standard procedures have not yet been established :-)  
Here's what I get:

+"structure factor amplitude"  18,000 hits
+"structure amplitude"         17,100 hits

        Ethan


> 
> Cheers
> 
> -- Ian
> 
> > -----Original Message-----
> > From: owner-ccp...@jiscmail.ac.uk 
> > [mailto:owner-ccp...@jiscmail.ac.uk] On Behalf Of Pavel Afonine
> > Sent: 11 January 2009 03:01
> > To: Ethan A Merritt
> > Cc: CCP4BB@jiscmail.ac.uk
> > Subject: Re: [ccp4bb] structure (factor) amplitude
> > 
> > 
> > 
> > On 1/10/2009 5:14 PM, Ethan A Merritt wrote: 
> > 
> >     On Saturday 10 January 2009, Bernhard Rupp wrote:
> >       
> > 
> >             Dear All,
> >             
> >             I am getting conflicting comments on the use of 
> >             'structure factor amplitude'
> >             vs. just
> >             'structure amplitude'
> >             for |F|.
> >                 
> > 
> >     
> >     ???
> >     That's just... odd.
> >     
> >     |F| is the amplitude of F.
> >     But no way F is a "structure".
> >       
> > 
> > 
> > I agree. If F is a structure factor then |F| is a structure 
> > factor amplitude. "structure amplitude" doesn't make much sense...
> > Pavel.
> 
> 
> Disclaimer
> This communication is confidential and may contain privileged information 
> intended solely for the named addressee(s). It may not be used or disclosed 
> except for the purpose for which it has been sent. If you are not the 
> intended recipient you must not review, use, disclose, copy, distribute or 
> take any action in reliance upon it. If you have received this communication 
> in error, please notify Astex Therapeutics Ltd by emailing 
> i.tic...@astex-therapeutics.com and destroy all copies of the message and any 
> attached documents. 
> Astex Therapeutics Ltd monitors, controls and protects all its messaging 
> traffic in compliance with its corporate email policy. The Company accepts no 
> liability or responsibility for any onward transmission or use of emails and 
> attachments having left the Astex Therapeutics domain.  Unless expressly 
> stated, opinions in this message are those of the individual sender and not 
> of Astex Therapeutics Ltd. The recipient should check this email and any 
> attachments for the presence of computer viruses. Astex Therapeutics Ltd 
> accepts no liability for damage caused by any virus transmitted by this 
> email. E-mail is susceptible to data corruption, interception, unauthorized 
> amendment, and tampering, Astex Therapeutics Ltd only send and receive 
> e-mails on the basis that the Company is not liable for any such alteration 
> or any consequences thereof.
> Astex Therapeutics Ltd., Registered in England at 436 Cambridge Science Park, 
> Cambridge CB4 0QA under number 3751674
> 



-- 
Ethan A Merritt
Biomolecular Structure Center
University of Washington, Seattle 98195-7742

Reply via email to